1 July 2024 false No description of principal activity Taxfiler 2024.6 14204389 business:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 14204389 2024-06-30 14204389 2024-07-01 2025-06-30 14204389 business:AuditExempt-NoAccountantsReport 2024-07-01 2025-06-30 14204389 business:FilletedAccounts 2024-07-01 2025-06-30 14204389 2025-06-30 14204389 business:Director1 2024-07-01 2025-06-30 14204389 business:RegisteredOffice 2024-07-01 2025-06-30 14204389 2024-06-30 14204389 core:WithinOneYear 2025-06-30 14204389 core:WithinOneYear 2024-06-30 14204389 core:ShareCapital core:PreviouslyStatedAmount 2025-06-30 14204389 core:ShareCapital core:PreviouslyStatedAmount 2024-06-30 14204389 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-06-30 14204389 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-06-30 14204389 core:PreviouslyStatedAmount 2025-06-30 14204389 core:PreviouslyStatedAmount 2024-06-30 14204389 business:SmallEntities 2024-07-01 2025-06-30 14204389 countries:EnglandWales 2024-07-01 2025-06-30 14204389 core:PlantMachinery 2024-06-30 14204389 core:FurnitureFittings 2024-06-30 14204389 core:PlantMachinery 2024-07-01 2025-06-30 14204389 core:FurnitureFittings 2024-07-01 2025-06-30 14204389 core:PlantMachinery 2025-06-30 14204389 core:FurnitureFittings 2025-06-30 14204389 2023-07-01 2024-06-30 iso4217:GBP xbrli:pure
Company Registration No. 14204389 (England and Wales)
LANCASHIRE MEDSPLUS LTD Unaudited accounts for the year ended 30 June 2025
LANCASHIRE MEDSPLUS LTD Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
LANCASHIRE MEDSPLUS LTD Company Information for the year ended 30 June 2025
Director
Afsheen KHAN
Company Number
14204389 (England and Wales)
Registered Office
Unit 5, The Watermark 9-15 Ribbleton Lane Preston PR1 5EZ United Kingdom
- 3 -
LANCASHIRE MEDSPLUS LTD Statement of financial position as at 30 June 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
35,909
24,743
Current assets
Debtors
5
1,831
10,185
Cash at bank and in hand
516
1,958
2,347
12,143
Creditors: amounts falling due within one year
6
(105,577)
(78,336)
Net current liabilities
(103,230)
(66,193)
Net liabilities
(67,321)
(41,450)
Capital and reserves
Called up share capital
100
100
Profit and loss account
(67,421)
(41,550)
Shareholders' funds
(67,321)
(41,450)
For the year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 10 March 2026 and were signed on its behalf by
Afsheen KHAN Director Company Registration No. 14204389
- 4 -
LANCASHIRE MEDSPLUS LTD Notes to the Accounts for the year ended 30 June 2025
1
Statutory information
LANCASHIRE MEDSPLUS LTD is a private company, limited by shares, registered in England and Wales, registration number 14204389. The registered office is Unit 5, The Watermark, 9-15 Ribbleton Lane, Preston, PR1 5EZ, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
4
Tangible fixed assets
Plant & machinery
Fixtures & fittings
Total
£
£
£
Cost or valuation
At cost
At cost
At 1 July 2024
-
24,743
24,743
Additions
1,166
10,000
11,166
At 30 June 2025
1,166
34,743
35,909
Depreciation
At 30 June 2025
-
-
-
Net book value
At 30 June 2025
1,166
34,743
35,909
At 30 June 2024
-
24,743
24,743
5
Debtors
2025
2024
£
£
Amounts falling due within one year
VAT
1,831
10,185
- 5 -
LANCASHIRE MEDSPLUS LTD Notes to the Accounts for the year ended 30 June 2025
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
-
1,114
Other creditors
30,563
32,208
Loans from directors
75,014
45,014
105,577
78,336
7
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 6 -